Growing community of inventors

N. Billerica, MA, United States of America

Sara A Waggener

Average Co-Inventor Count = 10.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 38

Sara A WaggenerAles Medek (3 patents)Sara A WaggenerEleni Dokou (3 patents)Sara A WaggenerLori Ann Ferris (3 patents)Sara A WaggenerDragutin Knezic (3 patents)Sara A WaggenerKatie McCarty (3 patents)Sara A WaggenerGeoffrey Glen Brodeur (3 patents)Sara A WaggenerSachin Chandran (3 patents)Sara A WaggenerLaurent Jean-Claude Bagnol (3 patents)Sara A WaggenerBrian Dean Phenix (3 patents)Sara A WaggenerKatie Lynn Mccarty (0 patent)Sara A WaggenerAles Medek (0 patent)Sara A WaggenerEleni Dokou (0 patent)Sara A WaggenerDragutin Knezic (0 patent)Sara A WaggenerLaurent Jean-Claude Bagnol (0 patent)Sara A WaggenerSachin Chandran (0 patent)Sara A WaggenerKatie Lynn Mccarty (0 patent)Sara A WaggenerKatie Lynn Mccarty (0 patent)Sara A WaggenerSara A Waggener (3 patents)Ales MedekAles Medek (22 patents)Eleni DokouEleni Dokou (12 patents)Lori Ann FerrisLori Ann Ferris (11 patents)Dragutin KnezicDragutin Knezic (9 patents)Katie McCartyKatie McCarty (5 patents)Geoffrey Glen BrodeurGeoffrey Glen Brodeur (3 patents)Sachin ChandranSachin Chandran (3 patents)Laurent Jean-Claude BagnolLaurent Jean-Claude Bagnol (3 patents)Brian Dean PhenixBrian Dean Phenix (3 patents)Katie Lynn MccartyKatie Lynn Mccarty (0 patent)Ales MedekAles Medek (0 patent)Eleni DokouEleni Dokou (0 patent)Dragutin KnezicDragutin Knezic (0 patent)Laurent Jean-Claude BagnolLaurent Jean-Claude Bagnol (0 patent)Sachin ChandranSachin Chandran (0 patent)Katie Lynn MccartyKatie Lynn Mccarty (0 patent)Katie Lynn MccartyKatie Lynn Mccarty (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Vertex Pharmaceuticals, Inc. (3 from 1,149 patents)


3 patents:

1. 11951212 - Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

2. 10980746 - Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

3. 10206877 - Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…